541 related articles for article (PubMed ID: 18818980)
101. Laparoscopic gastric bypass with subtotal gastrectomy for a super-obese patient with Biermer anemia.
Sodji M; Sebag FA; Catheline JM
Obes Surg; 2007 Aug; 17(8):1132-5. PubMed ID: 17953252
[TBL] [Abstract][Full Text] [Related]
102. Cocaine and amphetamine regulated transcript and brain-derived neurotrophic factor in morbid obesity. One-year follow-up after gastric bypass.
Muñoz-Rodríguez JR; Agarrado A; Martín-Fernández J; Salas E; González-Martín C; Alguacil LF
Surg Obes Relat Dis; 2018 Nov; 14(11):1732-1739. PubMed ID: 30274741
[TBL] [Abstract][Full Text] [Related]
103. Facilitating retrocolic-retrogastric gastrojejunostomy in laparoscopic Roux-en-Y gastric bypass for morbid obesity.
Clements RH; Harper HC; Laws HL
J Am Coll Surg; 2001 Sep; 193(3):331-2. PubMed ID: 11548806
[No Abstract] [Full Text] [Related]
104. Laparoscopic Roux-en-Y gastric bypass in morbidly obese patients > or =55 years old.
Fazylov R; Soto E; Merola S
Obes Surg; 2008 Jun; 18(6):656-9. PubMed ID: 18408983
[TBL] [Abstract][Full Text] [Related]
105. Development of an Interactive Outcome Estimation Tool for Laparoscopic Roux-en-Y Gastric Bypass in Mexico Based on a Cohort of 1002 Patients.
Velázquez-Fernández D; Sánchez H; Monraz F; Zanela OO; Cabra HA; Pantoja JP; Sierra M; Mosti M; Herrera MF
Obes Surg; 2019 Sep; 29(9):2878-2885. PubMed ID: 31104284
[TBL] [Abstract][Full Text] [Related]
106. Study protocol of the DUCATI-study: a randomized controlled trial investigating the optimal common channel length in laparoscopic gastric bypass for morbid obese patients.
Gadiot RP; Grotenhuis BA; Biter LU; Dunkelgrun M; Zengerink HJ; Feskens PB; Mannaerts GH
BMC Obes; 2015; 2():28. PubMed ID: 26217543
[TBL] [Abstract][Full Text] [Related]
107. The effect of laparoscopic Roux-en-Y gastric bypass on fibromyalgia.
Saber AA; Boros MJ; Mancl T; Elgamal MH; Song S; Wisadrattanapong T
Obes Surg; 2008 Jun; 18(6):652-5. PubMed ID: 18401670
[TBL] [Abstract][Full Text] [Related]
108. Concomitant cholecystectomy during laparoscopic Roux-en-Y gastric bypass in obese patients is not justified: a meta-analysis.
Warschkow R; Tarantino I; Ukegjini K; Beutner U; Güller U; Schmied BM; Müller SA; Schultes B; Thurnheer M
Obes Surg; 2013 Mar; 23(3):397-407. PubMed ID: 23315094
[TBL] [Abstract][Full Text] [Related]
109. Resolution of Uncontrolled Type 2 Diabetes after Laparoscopic Truncal Vagotomy, Subtotal Gastrectomy, and Roux-en-Y Gastrojejunostomy for a Patient with Intractable Gastric Ulcers.
Tait LF; Ortega G; Tran DD; Fullum TM
Case Rep Surg; 2012; 2012():102752. PubMed ID: 23198247
[TBL] [Abstract][Full Text] [Related]
110. Late results of gastric bypass surgery for morbid obesity.
Reinhold RB
J Am Coll Nutr; 1994 Aug; 13(4):326-31. PubMed ID: 7963136
[TBL] [Abstract][Full Text] [Related]
111. Intestinal malrotation discovered at the time of laparoscopic Roux-en-Y gastric bypass.
Palepu RP; Harmon CM; Goldberg SP; Clements RH
J Gastrointest Surg; 2007 Jul; 11(7):898-902. PubMed ID: 17487537
[TBL] [Abstract][Full Text] [Related]
112. Three-dimensional laparoscopic Roux-en-Y gastric bypass with totally hand-sewn anastomoses for morbid obesity. A single center experience.
Mongelli F; Regina D; Garofalo F; Vannelli A; Giuseppe MD; FitzGerald M; Marengo M
Acta Cir Bras; 2020 Sep; 35(8):e202000806. PubMed ID: 32901683
[TBL] [Abstract][Full Text] [Related]
113. Efficacy of Goal-Directed Fluid Therapy via Pleth Variability Index During Laparoscopic Roux-en-Y Gastric Bypass Surgery in Morbidly Obese Patients.
Demirel İ; Bolat E; Altun AY; Özdemir M; Beştaş A
Obes Surg; 2018 Feb; 28(2):358-363. PubMed ID: 28762023
[TBL] [Abstract][Full Text] [Related]
114. Vertical Gastric Bypass with Fundectomy: Feasibility and 2-Year Follow-Up in a Series of Morbidly Obese Patients.
Zappa MA; Aiolfi A; Musolino C; Giusti MP; Lesti G; Porta A
Obes Surg; 2017 Aug; 27(8):2145-2150. PubMed ID: 28271378
[TBL] [Abstract][Full Text] [Related]
115. Laparoscopic approach to open gastric bypass.
Harold KL; Heniford BT; Matthews BD; Sing RF
Am J Surg; 2002 Jul; 184(1):61-2. PubMed ID: 12135723
[TBL] [Abstract][Full Text] [Related]
116. Frequency and causes of conversion from laparoscopic to open Roux-en-Y gastric bypass for morbid obesity: the experience in our service.
Gonzalez Valverde FM; Cifuentes AS; Marin MR; Rodriguez MT; Moncada JR; Marin-Blazquez AA
Obes Surg; 2013 Mar; 23(3):391-2. PubMed ID: 23239031
[No Abstract] [Full Text] [Related]
117. Metabolic syndrome after Roux-en-Y gastric bypass in patients with morbid obesity: Five years of follow-up, a before and after study.
Rodríguez-Álvarez C; Acosta-Torrecilla AO; González-Dávila E; Arias Á
Int J Surg; 2020 Feb; 74():5-10. PubMed ID: 31874260
[TBL] [Abstract][Full Text] [Related]
118. Autopsy findings following gastric bypass surgery for morbid obesity.
Melinek J; Livingston E; Cortina G; Fishbein MC
Arch Pathol Lab Med; 2002 Sep; 126(9):1091-5. PubMed ID: 12204059
[TBL] [Abstract][Full Text] [Related]
119. The Treatment of Achalasia in Obese Patients.
Wesp JA; Farrell TM
Am Surg; 2018 Apr; 84(4):501-505. PubMed ID: 29712596
[TBL] [Abstract][Full Text] [Related]
120. The Impact of Laparoscopic Gastric Bypass on Comorbidities and Quality of Life in the Older Obese Patients (Age > 60): Our UK Experience.
Almerie MQ; Rao VSR; Peter MB; Sedman P; Jain P
Obes Surg; 2018 Dec; 28(12):3890-3894. PubMed ID: 30056573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
